JAMES R. SULAT

Insider Reports History

Signature
/s/ Mark Tyndall, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by JAMES R. SULAT:

Company Role Class Num Shares Value Price $ Report Date Ownership
Arch Therapeutics, Inc. Director Stock Option (right to buy) 250,000 27 Sep 2021 Direct
EXICURE, INC. Director Employee Stock Option (right to buy) 50,000 13 Jun 2022 Direct
Mallinckrodt plc Director Ordinary Shares 0 $37.50 14 Nov 2023 Direct

Insider Reports Filed by JAMES R. SULAT

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000110465923119106-sulat-james-r-2023-11-14 Mallinckrodt plc 14 Nov 2023 1 $0 4 Director 16 Nov 2023, 16:12
/report/000110465923076465-sulat-james-r-2023-06-16 Mallinckrodt plc 16 Jun 2023 2 -$4,037 4 Director 29 Jun 2023, 18:50
/report/000110465923033302-sulat-james-r-2023-03-14 Mallinckrodt plc 14 Mar 2023 2 +$254,475 4 Director 16 Mar 2023, 16:05
/report/000110465923001541-sulat-james-r-2023-01-03 Mallinckrodt plc 03 Jan 2023 1 $0 4 Director 05 Jan 2023, 17:01
/report/000110465922100151-sulat-james-r-2022-08-16 Mallinckrodt plc 16 Aug 2022 1 $0 4 Director 14 Sep 2022, 21:16
/report/000089924322025533-sulat-james-r-2022-07-01 Mallinckrodt plc 01 Jul 2022 1 $0 4 Director 06 Jul 2022, 21:08
/report/000089924322023968-sulat-james-r-2022-06-16 Mallinckrodt plc 16 Jun 2022 0 $0 3 Director 24 Jun 2022, 16:28
XCUR EXICURE, INC. 13 Jun 2022 1 $0 4 Director 15 Jun 2022, 16:19
ARTHQ Arch Therapeutics, Inc. 27 Sep 2021 2 $0 4 Director 01 Oct 2021, 08:14
XCUR EXICURE, INC. 02 Jun 2021 1 $0 4 Director 04 Jun 2021, 17:20